Contents: Research LetterSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination in Pregnancy Measures of Immunity and Placental HistopathologyShanes, Elisheva D. MD; Otero, Sebastian BA; Mithal, Leena B. MD, MSCI; Mupanomunda, Chiedza A. BS; Miller, Emily S. MD, MPH; Goldstein, Jeffery A. MD, PhD Author Information Feinberg School of Medicine, Northwestern University, and the Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. Corresponding author: Jeffery A. Goldstein, MD, PhD, Olson 2-455, Feinberg School of Medicine, Chicago IL; email: [email protected]. Financial Disclosure The authors did not report any potential conflicts of interest. Supported by the Friends of Prentice (funder) and NIBIB K08EB030120 (to JAG), Stanley Manne Research Institute and K23AI139337 (to LBM). Each author has confirmed compliance with the journal's requirements for authorship. Published online ahead-of-print May 11, 2021. Peer reviews and author correspondence are available at https://links.lww.com/AOG/C331. Obstetrics & Gynecology 138(2):p 281-283, August 2021. | DOI: 10.1097/AOG.0000000000004457 Buy Metrics In Brief Receipt of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination was not associated with placental histopathologic lesions. © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.